Literature DB >> 1743247

Enhancement of propoxyphene bioavailability by ethanol. Relation to psychomotor and cognitive function in healthy volunteers.

C Girre1, M Hirschhorn, L Bertaux, S Palombo, F Dellatolas, R Ngo, M Moreno, P E Fournier.   

Abstract

The interaction between a single oral dose of 130 mg propoxyphene and 0.5 g/kg body weight ethanol was investigated in 12 healthy male volunteers by 9 objective performance tests, 8 visual analogue self-rating scales and the measurement of plasma propoxyphene, norpropoxyphene and ethanol concentrations, using a double-blind threeway crossover design. Volunteers were each given one of three treatments, propoxyphene + ethanol, placebo + ethanol and propoxyphene alone, separated by a two week interval. The performance tests were completed before and 1.25 and 4 h after drug intake, and the self-rating scales before and 1.25, 4 and 10 h after it. Ethanol was shown to enhance the bioavailability of propoxyphene by 25% probably by reducing its first-pass metabolism. However, despite this pharmacokinetic effect no pharmacodynamic interaction was found. Subjective ratings disclosed that the effect of ethanol on physical and mental sedation predominated over the effects of propoxyphene.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1743247     DOI: 10.1007/BF00265908

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  15 in total

1.  THE EFFECT OF ETHANOL UPON SYSTEMIC AND HEPATIC BLOOD FLOW IN MAN.

Authors:  S W Stein; C S Lieber; C M Leevy; G R Cherrick; W H Abelmann
Journal:  Am J Clin Nutr       Date:  1963-08       Impact factor: 7.045

2.  Effect of combined alcohol and propoxyphene on human performance.

Authors:  G F Kiplinger; G Sokol; B E Rodda
Journal:  Arch Int Pharmacodyn Ther       Date:  1974-11

Review 3.  Psychomotor function and psychoactive drugs.

Authors:  I Hindmarch
Journal:  Br J Clin Pharmacol       Date:  1980-09       Impact factor: 4.335

4.  Acute effect of ethanol on hepatic first-pass elimination of propoxyphene in rats.

Authors:  T Oguma; G Levy
Journal:  J Pharmacol Exp Ther       Date:  1981-10       Impact factor: 4.030

Review 5.  Ethanol metabolism and ethanol-drug interactions.

Authors:  E Mezey
Journal:  Biochem Pharmacol       Date:  1976-04-15       Impact factor: 5.858

6.  d-Propoxyphene kinetics after single oral and intravenous doses in man.

Authors:  L F Gram; J Schou; W L Way; J Heltberg; N O Bodin
Journal:  Clin Pharmacol Ther       Date:  1979-10       Impact factor: 6.875

7.  Ethanol interaction with propoxyphene and norpropoxyphene metabolism in isolated rat hepatocytes.

Authors:  H Olsen; E Bodd; T Meyer; J Mørland
Journal:  Pharmacol Biochem Behav       Date:  1983       Impact factor: 3.533

8.  Studies on performance with aspirin and paracetamol and with the centrally acting analgesics meptazinol and pentazocine.

Authors:  C M Bradley; A N Nicholson
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

9.  Comparison of the effects of therapeutic doses of meptazinol and a dextropropoxyphene/paracetamol mixture alone and in combination with ethanol on ventilatory function and saccadic eye movements.

Authors:  N A Ali; R W Marshall; E M Allen; D F Graham; A Richens
Journal:  Br J Clin Pharmacol       Date:  1985-12       Impact factor: 4.335

10.  Pharmacokinetic interaction of propoxyphene with ethanol.

Authors:  E M Sellers; C A Hamilton; H L Kaplan; N C Degani; R L Foltz
Journal:  Br J Clin Pharmacol       Date:  1985-03       Impact factor: 4.335

View more
  5 in total

1.  Subjective, psychomotor, and physiological effects of oxycodone alone and in combination with ethanol in healthy volunteers.

Authors:  James P Zacny; Sandra Gutierrez
Journal:  Psychopharmacology (Berl)       Date:  2011-05-21       Impact factor: 4.530

Review 2.  Pharmacokinetic and pharmacodynamic drug interactions with ethanol (alcohol).

Authors:  Lingtak-Neander Chan; Gail D Anderson
Journal:  Clin Pharmacokinet       Date:  2014-12       Impact factor: 6.447

Review 3.  Cholestasis and endogenous opioids: liver disease and exogenous opioid pharmacokinetics.

Authors:  Mellar Davis
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

4.  The cognitive and psychomotor effects of opioid analgesics. I. A randomized controlled trial of single doses of dextropropoxyphene, lorazepam and placebo in healthy subjects.

Authors:  W M O'Neill; G W Hanks; L White; P Simpson; K Wesnes
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

5.  Carisoprodol Single and Multiple Dose PK-PD. Part II: Pharmacodynamics Evaluation Method for Central Muscle Relaxants. Double-Blind Placebo-Controlled Clinical Trial in Healthy Volunteers.

Authors:  Aitana Calvo; Mercedes González-Hidalgo; Ana Terleira; Nieves Fernández; Antonio Portolés
Journal:  J Clin Med       Date:  2022-02-21       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.